Ancillary Testing for the Diagnosis of Pancreatic Ductal Adenocarcinoma
Over the last decade, the molecular biology of pancreatic ductal adenocarcinoma (PDA) has been, the subject of intense investigation. As a result, our understanding of the pathogenesis of PDA has significantly advanced. This chapter discusses some of these advances and how they and other developments have facilitated ancillary testing of cytologic samples for the diagnosis of PDA.
KeywordsPancreatic Ductal Adenocarcinoma Intraductal Papillary Mucinous Neoplasm Prostate Stem Cell Antigen Ancillary Test Pancreatic Ductal Carcinoma
Unable to display preview. Download preview PDF.